Arkansas · A9521

Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries in Arkansas

Arkansas Medicare Avg
$1,717.78
29% above national avg
National Medicare Avg
$1,336.62
All states combined
Billed Charge (AR)
$5,455.00
What providers submit
Est. Commercial (AR)
$4,527.57
National avg: $3,757.14
Est. Cash / Self-Pay (AR)
$3,117.11
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

15
Services in AR
5
Providers
N/A
Min Payment
N/A
Max Payment

Arkansas Pricing in Context

In Arkansas, CPT code A9521 (Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries) carries an average Medicare payment of $1,717.78 — 29% above the national benchmark of $1,336.62. 5 providers across the state submitted claims for this procedure in 2023, performing 15 total services. Individual payments in AR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Arkansas is $5,455.00, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Arkansas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Arkansas lands near $4,527.57, with self-pay cash prices typically around $3,117.11. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries cost in Arkansas?

The average Medicare payment for Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries in Arkansas is $1,717.78, which is 29% above the national average of $1,336.62. Providers in AR typically bill $5,455.00 for this procedure.

What does Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries cost with insurance in Arkansas?

With commercial insurance in Arkansas, Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries costs an estimated $4,527.57. Without insurance, the estimated cash price is $3,117.11. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries in Arkansas?

5 providers in Arkansas billed Medicare for Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries in 2023, performing 15 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries cheaper in Arkansas than the national average?

No — Technetium Tc-99m Exametazime, Diagnostic, Per Study Dose, Up To 25 Millicuries costs 29% above the national average in Arkansas. The state average Medicare payment is $1,717.78 compared to $1,336.62 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial